|
Quantitative MRI for Predicting Response of Breast Cancer to Neoadjuvant Therapy
|
5U01CA142565-10
|
$461,172
|
$230,586
|
ABRAMSON, RICHARD
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
COG NCTN Network Group Operations Center
|
5U10CA180886-05
|
$20,853,800
|
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Elucidation and therapeutic exploitation of PAK mediated radioresistance
|
1R37CA215081-01A1
|
$357,803
|
|
ADVANI, SUNIL
|
UNIVERSITY OF CALIFORNIA, SAN DIEGO
|
|
Quantitative Radiomics System Decoding the Tumor Phenotype
|
5U24CA194354-04
|
$683,694
|
|
AERTS, HUGO
|
DANA-FARBER CANCER INST
|
|
Targeting SHP2 as a precision medicine for the treatment of HER2-positive breast cancer
|
1R01CA213996-01A1
|
$343,125
|
|
AGAZIE, YEHENEW
|
WEST VIRGINIA UNIVERSITY
|
|
Functional Determinants of Metastatic Dormancy
|
5R01CA109182-15
|
$423,844
|
|
AGUIRRE-GHISO, JULIO
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
Assessment of sensory gating, attention, and executive control in breast cancer
|
1R01CA218496-01A1
|
$687,576
|
|
AHLES, TIM
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
The role of the SCF/FBW7 ubiquitin ligase complex in hematopiesis and leukemia.
|
5R01CA133379-10
|
$381,375
|
|
AIFANTIS, IANNIS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Long non-coding RNAs in hematopoiesis and blood malignancy
|
5R01CA194923-04
|
$457,533
|
|
AIFANTIS, IANNIS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Advancing the translatability of mouse models for cancer immunotherapy
|
1R01CA210561-01A1
|
$587,737
|
|
AKHURST, ROSEMARY
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Lymphatic and systemic immunity changes in post-radiation lymphedema development
|
5R01CA201487-03
|
$357,343
|
|
ALDRICH, MELISSA
|
UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
|
|
Rapid Point of Care Detection of HPV-Associated Malignancies
|
5UG3CA211415-02
|
$338,933
|
|
ANDERSON, KAREN
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Quantitative MRI Radiomics of Breast Cancer in Assessment of Malignancy and Response to Therapy
|
1F31CA221193-01A1
|
$26,048
|
|
ANTROPOVA, NATALIA
|
UNIVERSITY OF CHICAGO
|
|
HER2-pretargeting image-guided therapy of breast cancer
|
5R01CA209884-02
|
$393,896
|
|
ARTEMOV, DMITRI
|
JOHNS HOPKINS UNIVERSITY
|
|
Cancer Center Support Grant
|
2P30CA082103-19
|
$7,954,381
|
$159,088
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-19S1
|
$84,000
|
$1,680
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-19S2
|
$206,488
|
$4,130
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-19S3
|
$257,838
|
$5,157
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Targeting the TGIF/Twist1 network in osteosarcoma
|
5R01CA210911-02
|
$348,844
|
|
ATFI, AZEDDINE
|
UNIVERSITY OF MISSISSIPPI MED CTR
|
|
Behavioral Activation for Smoking Cessation and the Prevention of Post-Cessation Weight Gain
|
5R01CA206058-03
|
$634,518
|
|
AUDRAIN-MCGOVERN, JANET
|
UNIVERSITY OF PENNSYLVANIA
|
|
A Major Nutritional Effect on Intestinal Stem Cells and Tumors
|
1R01CA214625-01A1
|
$294,022
|
|
AUGENLICHT, LEONARD
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Mechanism of non-oncogene addiction
|
1R01CA211594-01A1
|
$363,713
|
|
AZAM, MOHAMMAD
|
CINCINNATI CHILDRENS HOSP MED CTR
|
|
Clinical Translation of Nuclear Export Inhibitor in Metastatic Pancreatic Cancer
|
1R37CA215427-01A1
|
$352,275
|
|
AZMI, ASFAR
|
WAYNE STATE UNIVERSITY
|
|
Clinical Translation of Nuclear Export Inhibitor in Metastatic Pancreatic Cancer
|
1R37CA215427-01A1
|
$352,275
|
$176,138
|
AZMI, ASFAR
|
WAYNE STATE UNIVERSITY
|
|
The contribution of the innate immune sensor STING in GVHD and GVL following allogeneic hematopoietic stem cell transplantation
|
1F31CA216999-01A1
|
$44,524
|
|
BADER, CAMERON
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
Role of Receptor for Advanced Glycation End Product (RAGE) Pathway in Brain Tumors
|
5R01CA155769-07
|
$410,877
|
|
BADIE, BEHNAM
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Obesity-driven Metabolic and Molecular Biomarkers of Metformin Response in Endometrial Cancer
|
1R37CA226969-01
|
$355,706
|
$117,383
|
BAE-JUMP, VICTORIA
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
2P30CA014520-44
|
$4,590,130
|
$45,901
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S1
|
$250,000
|
$2,500
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S2
|
$136,232
|
$1,362
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S3
|
$75,711
|
$757
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S4
|
$31,772
|
$318
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Phase I trial of intravenous vesicular stomatitis virus for treatment of metastatic endometrial cancer
|
5R01CA207240-02
|
$543,708
|
|
BAKKUM-GAMEZ, JAMIE
|
MAYO CLINIC ROCHESTER
|
|
7T Neurosurgical Mapping Protocol for Endoscopic Resection of Skull Base Tumors
|
5R01CA202911-03
|
$387,731
|
|
BALCHANDANI, PRITI
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
SOX9 Mediation of AR and ERG Driven Prostate Cancer
|
5R01CA168393-05
|
$361,050
|
|
BALK, STEVEN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Structure, Function, and Inhibition of the RhoGEF Trio - a Target in Uveal Melanoma
|
1F31CA224804-01A1
|
$35,917
|
|
BANDEKAR, SUMIT
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Functional Significance of CD133 in Pancreatic Cancer
|
5R01CA184274-05
|
$318,513
|
|
BANERJEE, SULAGNA
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
Metabolic and signaling control of tumorformation in drosophila
|
5R01CA217608-28
|
$352,275
|
|
BANERJEE, UTPAL
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Functional Inhibition of Deubiquitylase HAUSP to Disrupt Glioblastoma Stem Cells
|
5R01CA184090-04
|
$362,569
|
|
BAO, SHIDENG
|
CLEVELAND CLINIC LERNER COM-CWRU
|
|
Mapping druggable co-dependency pathways in NRF2-driven lung cancers
|
5K99CA215249-02
|
$114,750
|
|
BAR-PELED, LIRON
|
SCRIPPS RESEARCH INSTITUTE
|
|
Targeting the cytokine circuitry of KRAS-driven lung cancer
|
5R01CA190394-04
|
$394,578
|
|
BARBIE, DAVID
|
DANA-FARBER CANCER INST
|
|
Fundamental subcortical mechanisms of affective processing
|
5U01CA193632-03
|
$350,973
|
|
BARRETT, LISA
|
NORTHEASTERN UNIVERSITY
|
|
The Role of RHOA in Diffuse Gastric Cancer
|
1R01CA224428-01
|
$677,302
|
|
BASS, ADAM
|
DANA-FARBER CANCER INST
|
|
U.T. M. D. Anderson Cancer Center SPORE in Ovarian Cancer
|
5P50CA217685-02
|
$1,813,624
|
$362,725
|
BAST, ROBERT
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
MD Anderson Cancer Center EDRN- CVC for Early Detection of Ovarian Cancer
|
5U01CA200462-03
|
$910,580
|
|
BAST, ROBERT
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Annual International Primary CNS Lymphoma Collaborative Group Meeting
|
2R13CA124293-11
|
$5,000
|
|
BATCHELOR, TRACY
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
MIC-1 and its functional partners in prostate cancer racial disparity
|
5U01CA185148-04
|
$312,080
|
|
BATRA, SURINDER
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
MIC-1 and its functional partners in prostate cancer racial disparity
|
5U01CA185148-04
|
$312,080
|
$102,986
|
BATRA, SURINDER
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
Identifying the Molecular and Cellular Basis of Invasive Phenotype in Human DCIS
|
5R01CA207445-02
|
$571,242
|
|
BEHBOD, FARIBA
|
UNIVERSITY OF KANSAS MEDICAL CENTER
|
|
Dietary fats, mitochondrial function and muscle health in cancer patients
|
1R21CA209566-01A1
|
$199,655
|
|
BELURY, MARTHA
|
OHIO STATE UNIVERSITY
|
Total relevant funding to Taxol for this search: $29,449,794
|